Institutional Review Board (IRB)
Standard Operating Procedures (SOP)
Date of Issue
September 2025
Approved By
Next Review Date
Next Review Date
September 2027
1. Purpose
The Institutional Review Board (IRB) ensures the ethical and scientific integrity of all research conducted at the National Institute of Physical therapy and Rehabilitation Sciences (NIPARS). It safeguards the rights, safety, and well-being of research participants by reviewing, approving, and monitoring studies.
2. Scope
This SOP applies to all research involving human participants conducted under NIPARS. External institutions, researchers, or companies may also seek IRB review after fulfilling required conditions and paying applicable fees.
3. Definitions
IRB: Institutional Review Board – an independent ethics committee responsible for research oversight.
PI: Principal Investigator – the lead researcher responsible for conducting the study.
Protocol: The detailed research plan submitted for IRB approval.
Amendment: Any change to an already approved protocol requiring IRB re-approval.
4. Membership
The IRB shall comprise scientists, healthcare professionals, lawyers, nurses, religious scholars, and ethics experts. Disciplines such as epidemiology, pharmacology, psychology, sociology, and biostatistics are recommended. Membership tenure is two years.
5. Responsibilities
Chairperson: Leads meetings, ensures impartial review, signs approvals.
Members: Review protocols, provide feedback, ensure compliance with ethical guidelines.
Principal Investigator: Submits documents, implements approved protocols, reports amendments and final results.
6. Meeting Schedule
The IRB meets on the first Saturday of every fourth month. Special meetings may be convened if required.
7. Procedure
Applications must be submitted at least 14 days prior to the scheduled meeting. No data collection may begin without IRB approval.
Required documents include:
– IRB Submission Form
– Research protocol/amendments
– Investigator’s brochure (if applicable)
– Informed consent forms
– Recruitment materials (if any)
– Compensation details
– Adverse event reporting plan
– Quality control reports
– Institutional approvals (if applicable)
– PI’s CV
– Revised versions clearly labeled
8. Types of Review
Exempt Review: Educational and minimal-risk studies as per policy.
Fast Track Review: Questionnaire/survey-based or no-risk studies reviewed by Chair + 1 member.
Full Board Review: All other studies requiring comprehensive review.
9. Principal Investigator (PI)
For student research, the PI is the supervisor or designated faculty member responsible for oversight.
10. Processing Fee
– NIPARS students and faculty: No fee
– External academic investigators: Rs. 10,000
– Pharmaceutical companies: Rs. 100,000
– If NIPARS faculty assist in external studies, they must be listed as co-investigators
11. Record Keeping & Confidentiality
The IRB will maintain all protocols, approvals, amendments, and correspondence in a secure archive. Confidentiality of applicants and study participants must be strictly preserved.
12. Compliance Statement
The IRB operates in compliance with international ethical standards, including the Declaration of Helsinki, CIOMS Guidelines, and ICH-GCP. All researchers must adhere to these principles.
13. Review and Amendment of SOPs
This SOP will be reviewed every two years or earlier if required. Amendments will be approved by the IRB Chairperson.
14. Final Report
Upon study completion, the PI must submit a final report. Any protocol amendments must be submitted for approval before implementation, except where immediate hazards to participants must be eliminated.